Atlas Trials

Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season

Clinical trial NCT01649713 · COMPLETED

Trial details

NCT number
NCT01649713
Sponsor
Fluart Innovative Vaccine Ltd, Hungary
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Influenza
Start date
2012-08-01
Primary completion
2012-09-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.